13F

Stock

Theravance Biopharma, Inc.

TBPH · held by 8 managers

Reported value

$19.7M

Holders

8

+1 new · −0 exited

Holders’ est. mark

$411.9K

Price effect on 1 books still in the name

Largest holder

$8.75M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY599.6K$8.75MHeld
BANK OF AMERICA CORP /DE/527.1K$7.7MHeld
BARCLAYS PLC115.4K$1.68M$411.9KAdded$230.9K
Militia Capital Partners, LP54.2K$791.3KHeld
TUDOR INVESTMENT CORP ET AL51K$745.3KHeld
Allworth Financial LP212$3.1KHeld
IFP Advisors, Inc3$44Held
Essential Partners LLC2$29New

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.